Bifogade filer
FluoGuide in advanced negotiations on collaboration agreement with a world leading medical technology company
Prenumeration
Beskrivning
| Land | Danmark |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Copenhagen, Denmark, 28 October 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in precision cancer surgery, announces to be in advanced negotiations regarding a collaboration agreement with a world leading medical technology company.
FluoGuide is in advanced negotiations with a world leading medical technology company on a collaboration agreement within head and neck cancer surgery where the aim is to optimize the usage of imaging systems and FG001 to enable better treatment for patients with cancer. This is in line with communicated anticipation.
The objective of the collaboration is to develop FG001 for tumor imaging and surgical margins assessment for head and neck cancer. The focus of the agreement will be to support the clinical phase and to gather a body of evidence on the technology platforms of the collaboration partner.
The content and the terms of the collaboration agreement is in line with the collaboration agreements the Company has entered with Intuitive Surgical, Olympus and SurgVision over the last 18 months.
The agreement will have no initial payment and will be non-exclusive. The terms of the agreement will not be disclosed, and the agreement will not have an impact on the Company’s financial results in 2025 and 2026.